Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue SUPPL. A, 1999, Pages 107-113

  Destache, Christopher J ^a,b   Dewan, Naresh ^a   O'Donohue, Walter J ^a   Campbell, J Clayton ^a   Angelillo, Vito A ^a  

^a CREIGHTON UNIVERSITY   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF PHARMACY AND HEALTH PROFESSIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFPROZIL; CEFRADINE; CEFUROXIME; CIPROFLOXACIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST BENEFIT ANALYSIS; DRUG COST; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTPATIENT; REVIEW; TREATMENT FAILURE;

ACUTE DISEASE; ADULT; AGED; ANTI-INFECTIVE AGENTS; BRONCHITIS; CHRONIC DISEASE; CIPROFLOXACIN; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES;

EID: 0032973721     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Woolcock, A. J. (1989). Epidemiology of chronic airways disease. Chest 96, Suppl. 3, 302S-6S.
2. Garibaldi, R. A. (1985). Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact. American Journal of Medicine 78, Suppi. 6B, 32-7.
3. Lode, H. (1991). Respiratory tract infections: when is antibiotic therapy indicated? Clinical Therapeutics 13, 149-56.
4. Gleckman, R. A. (1987). Bronchial infections: acute bronchitis and acute exacerbation of chronic bronchitis. Comprehensive Therapy, 13, 44-8.
5. Jorgensen, J. H., Doern, G. V., Maher, L. A. et al. (1990). Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrobial Agents and Chemotherapy 34, 2075-80.
6. Doern, G. V. (1995). Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract. American Journal of Medicine 99, Suppl. 6B, 3-7S.
7. Ball, A. P. & Tillotson, G. S. (1995). Lower respiratory tract infection therapy - the role of ciprofloxacin. Journal of International Medical Research 23, 315-27.
8. Dark, D. S. (1993). Azithromycin versus cefaclor in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Current Therapeutic Research - Clinical and Experimental 53, 203-11.
9. Kinasewitz, G. & Wood, R. G. (1991). Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia. European Journal of Clinical Microbiology and Infectious Diseases 10, 872-7.
10. Knaus, W. A., Harrell, F. E. J., Lynn, J., Goldman, L., Phillips, R. S., Connors, A. F. et al. (1995). The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognosis and preferences for outcomes and risks of treatments. Annals of Internal Medicine 122, 191-203.
11. Lange, P., Nyboe, J., Appleyard, M., Jensen, G. & Schnohr, P. (1990). Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 45, 579-85.
12. Sherman, C. B., Zu, X., Speizer, F. E., Ferris, B. G., Weiss, S. T. & Dockery, D. W. (1992). Longitudinal lung function decline in subjects with respiratory symptoms. American Review of Respiratory Disease 146, 855-9.
13. Elmes, P. C., King, T. K. C., Langlands, J. H. M., Mackay, J. A., Wallace, W. F., Wade, O. L. et al. (1965). Value of ampicillin in the hospital treatment of exacerbations of chronic bronchitis. British Medical Journal ii, 904-8.
14. Petersen, E. S., Esmann, V., Honcke, P. & Munkener, C. (1967). A controlled study of the effect of treatment of chronic bronchitis. An evaluation using pulmonary function tests. Acta Medica Scandinavica 182, 293-305.
15. Pines, A., Raafat, H., Greenfield, J. S. B., Linsell, W. D. & Solari, M. E. (1972). Antibiotic regimens in moderately ill patients with purulent exacerbations of chronic bronchitis. British Journal of Diseases of the Chest 66, 107-15.
16. Nicotra, M. B., Rivera, M. & Awe, R. J. (1982). Antibiotic therapy of acute exacerbations of chronic bronchitis. A controlled study using tetracycline. Annals of Internal Medicine 97, 18-21.
17. Anthonisen, N. R., Manfreda, J., Warran, C. P. W., Hershfield, G. S., Harding, G. K. & Nelson, N. A. (1987). Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Annals of Internal Medicine 106, 196-204.
18. Jorgensen, A. F., Coolidge, J., Pedersen, P. A., Petersen, K. P., Waldorff, S. & Widding, E. (1992). Amoxicillin in treatment of acute uncomplicated exacerbations of chronic bronchitis. A double-blind, placebo controlled multicentre study in general practice. Scandinavian Journal of Primary Health Care 10, 7-11.
19. Berry, D. G., Fry, J., Hindley, C. P., Hodson, J. M., Horder, E. J., Horder, J. P. et al. (1960). Exacerbations of chronic bronchitis treatment with oxytetracycline. Lancet i, 137-9.
20. Elmes, P. C., Fletchert, C. M. & Dutton, A. A. C. (1957). Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis. British Medical Journal ii, 1272-5.
21. Fear, E. C. & Edwards, G. (1962). Antibiotic regimens in chronic bronchitis. British Journal of Diseases of the Chest 56, 153-62.
22. Saint, S., Bent, S., Vittinghoff, E. & Grady, D. (1995). Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. Journal of the American Medical Association 273, 957-60.
23. Davies, J. (1994). Inactivation of antibiotics and the dissemination of resistance genes. Science 264, 375-82.
24. Cramer, J. A., Mattson, R. H., Prevey, M. L., Scheyer, R. D. & Ouellette, V. L. (1989). How often is medication taken as prescribed? A novel assessment technique. Journal of the American Medical Association 261, 3273-7.
25. 5. Kesten, S. & Chapman, K. R. (1993). Physician perceptions and management of COPD. Chest 104, 254-8.
26. Bergosfsky, E. H. (1991). The lung mucosa: a critical environmental battleground. American Journal of Medicine 91, Suppl. 4A, 4-10S
27. . 27. McHardy, V. U., Inglis, J. M., Calder, M. A., Crofton, J. W., Gregg, I., Ryland, D. A. et al. (1980). A study of infective and other factors in exacerbations of chronic bronchitis. British Journal of Diseases of the Chest 74, 228-38.
28. Ball, P., Harris, J. M., Lowson, D., Tillotson, G. & Wilson, R. (1995). Acute infective exacerbations of chronic bronchitis, Quarterly Journal of Medicine, 88, 61-8.
29. Blackhouse, R., Shakespeare, A. & Hutton, J. (1995). Economic evaluation of alternative antibiotic regimens in the management of acute exacerbations of chronic bronchitis. British Journal of Medical Economics 8, 11-25.
30. Chow, A. W., Hall, C. B., Klein, J. O., Kammer, R. B., Meyer, R. D. & Remington, J. S. (1992). Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Clinical Infectious Diseases 15, Suppl. 1, S62-88.
31. Balter, M. S., Hyland, R. H., Lowe, D. et al. (1994). Recommendations on the management of chronic bronchitis: a practical guide for Canadian physicians. Canadian Medical Association Journal 10, Suppl., 5-23.